Setmelanotide for the treatment of severe early-childhood genetic obesity.

Saved in:
Bibliographic Details
Title: Setmelanotide for the treatment of severe early-childhood genetic obesity.
Authors: Roth CL; Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA; Department of Pediatrics, University of Washington, School of Medicine, Seattle WA, USA.
Source: The lancet. Diabetes & endocrinology [Lancet Diabetes Endocrinol] 2025 Jan; Vol. 13 (1), pp. 3-4. Date of Electronic Publication: 2024 Nov 13.
Publication Type: Journal Article
Journal Info: Publisher: The Lancet, Diabetes & Endocrinology Country of Publication: England NLM ID: 101618821 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-8595 (Electronic) Linking ISSN: 22138587 NLM ISO Abbreviation: Lancet Diabetes Endocrinol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:2213-8595
DOI:10.1016/S2213-8587(24)00312-7